NO923533L - Nye 5-amino-4-hydroksyheksansyrederivater som terapeutika - Google Patents

Nye 5-amino-4-hydroksyheksansyrederivater som terapeutika

Info

Publication number
NO923533L
NO923533L NO92923533A NO923533A NO923533L NO 923533 L NO923533 L NO 923533L NO 92923533 A NO92923533 A NO 92923533A NO 923533 A NO923533 A NO 923533A NO 923533 L NO923533 L NO 923533L
Authority
NO
Norway
Prior art keywords
terminally
group
bonded
sulfo
amino acid
Prior art date
Application number
NO92923533A
Other languages
English (en)
Other versions
NO923533D0 (no
Inventor
Marc Lang
Guido Bold
Alexander Faessler
Peter Schneider
Peter Van Hoogevest
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO923533D0 publication Critical patent/NO923533D0/no
Publication of NO923533L publication Critical patent/NO923533L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Forbindelser med formel: H OH (D, der Rj betyr hydrogen, laverealkoksykarbonyl, heterocyklylliarbonyl, benzylokeykarbonyl, som kan være ueubstltuert eller substituert ved inntil tre uavhengige av hverandre fluor, halogenlaverealkyl, laverealkanoyl, sulfo, laverealkylsulfonyl og cyano utvalgte rester, heterocyklyloksykarbonyl, der heterocyklyl kan vasre bundet over et karbonatom, en av de nevnte karbonylrestene der den bindende karbonylgruppen er erstattet med en tlokarbonyl- gruppe, heterocyklylBUlfonyl, laverealkylsulfonyl eller N-(heterocyklyllaverealkyl)-N-laverealkylaminokarbonyl, 3^ betyr en binding eller et toverdig radikal av en a-aminosyre som kan være N-terminalt bundet med R! og C-termlnalt bundet med atninogruppen til R2-CH2-bærende karbonatom, R2 og R3 betyr uavhengig av hverandre fenyl eller cytlohek- syl, der restene kan være usubstituert eller substituert med en til tre uavhengig av hverandre hydroksy, lavere- alkoksy, halogen, halogenlaverealkyl, sulfo, laverealkylsulfonyl. cyano og nitro utvalgte rester, J^ betyr en binding mellom -C-0 og A2 eller et toverdig radikal av en a-amlnosyre, som kan vare N-terminalt bundet med gruppen -C-0 og C-termlnalt bundet med A2, A2 betyr en toverdig radikal av en a-aminosyre. som kan vare bundet N-terminalt med Aj og C-termlnalt med gruppen NR4RB, eller Aj og A2 sammen danner et toverdig radikal av et dlpeptld, hvis sentrale amidblndlng er redusert og forbundet N-termlnalt med gruppen -C-0 og C-termlnalt med gruppen NR4RB, og R4 og RB betyr sammen med det bindende nltrogenatomet usubstituert eller substituert tlomorfolino eller morfollno, og salter av disse forbindelsene så fremt saltdannende grupper foreligger, eller hydroksybeskyttende derivater av disse. Disse HIV-proteasehemmerne kan anvendes til behandling av AIDS.
NO92923533A 1991-09-12 1992-09-11 Nye 5-amino-4-hydroksyheksansyrederivater som terapeutika NO923533L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH268991 1991-09-12
CH98092 1992-03-27
CH200792 1992-06-25

Publications (2)

Publication Number Publication Date
NO923533D0 NO923533D0 (no) 1992-09-11
NO923533L true NO923533L (no) 1993-03-15

Family

ID=27172572

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923533A NO923533L (no) 1991-09-12 1992-09-11 Nye 5-amino-4-hydroksyheksansyrederivater som terapeutika

Country Status (15)

Country Link
EP (1) EP0532466A3 (no)
JP (1) JPH05230095A (no)
KR (1) KR930006050A (no)
AU (1) AU661018B2 (no)
CA (1) CA2077948A1 (no)
CZ (1) CZ280292A3 (no)
FI (1) FI924035A (no)
HU (1) HUT63632A (no)
IL (1) IL103126A (no)
MX (1) MX9205208A (no)
NO (1) NO923533L (no)
NZ (1) NZ244288A (no)
PL (1) PL169969B1 (no)
RU (1) RU2067585C1 (no)
SK (1) SK280292A3 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643878A (en) * 1991-09-12 1997-07-01 Ciba-Geigy Corporation 5-amino-4-hydroxyhexanoic acid derivatives
ATE253050T1 (de) 1992-03-11 2003-11-15 Narhex Ltd Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
CA2130754C (en) * 1992-03-11 2005-02-08 Damian W. Grobelny Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
TW217410B (no) * 1992-04-01 1993-12-11 Ciba Geigy
ES2093394T3 (es) 1992-12-23 1996-12-16 Ciba Geigy Ag Derivados de hidrazina antiretrovirales.
EP0618222A3 (en) * 1993-03-11 1997-01-02 Ciba Geigy Ag Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid.
EP0626178A1 (de) * 1993-05-17 1994-11-30 Ciba-Geigy Ag Verwendung von Hemmstoffen von HIV-Aspartatproteasen zur Bekämpfung von Tumorerkrankungen
IL110898A0 (en) * 1993-09-10 1994-11-28 Narhex Australia Pty Ltd Polar-substituted hydrocarbons
IL110752A (en) * 1993-09-13 2000-07-26 Abbott Lab Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
US5559158A (en) * 1993-10-01 1996-09-24 Abbott Laboratories Pharmaceutical composition
IL111991A (en) * 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
WO1996016980A1 (en) * 1994-11-29 1996-06-06 Novartis Ag Morpholinoethylamide derivatives
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
US5840835A (en) * 1995-10-30 1998-11-24 Merck & Co., Inc. Inhibitors of peptide binding to MHC class II proteins
US5817757A (en) * 1995-10-30 1998-10-06 Merck & Co., Inc. Inhibitors of peptide binding to MHO class II proteins
WO1997016188A1 (en) * 1995-10-30 1997-05-09 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins
US5914332A (en) 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
US6232333B1 (en) 1996-11-21 2001-05-15 Abbott Laboratories Pharmaceutical composition
US7553969B1 (en) * 1999-01-28 2009-06-30 Chugai Seiyaku Kabushiki Kaisha Substituted phenethylamine derivatives
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
KR100708221B1 (ko) 1999-08-31 2007-04-17 아지노모토 가부시키가이샤 에폭사이드 결정의 제조방법
SI1248600T1 (sl) 2000-01-19 2008-08-31 Abbott Lab Izboljšane farmacevtske formulacije inhibitorjev proteaze HIV
US6506786B2 (en) 2001-02-13 2003-01-14 Pharmacor Inc. HIV protease inhibitors based on amino acid derivatives
KR20050065661A (ko) * 2002-11-01 2005-06-29 비로파마 인코포레이티드 벤조푸란 화합물, 조성물 및 c형 간염 바이러스 감염 및관련 질병의 치료 및 예방 방법
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
US8227450B2 (en) 2005-11-30 2012-07-24 Ambrilia Biopharma Inc. Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation
CN101374815B (zh) 2006-01-27 2013-07-17 菲布罗根有限公司 使低氧诱导因子(hif)稳定的氰基异喹啉化合物
BRPI0710527B8 (pt) 2006-04-04 2021-05-25 Fibrogen Inc compostos de pirrolo- e tiazolo-piridina e composição farmacêutica que os compreende
US8410300B2 (en) 2006-09-21 2013-04-02 Taimed Biologics, Inc. Protease inhibitors
JP5649584B2 (ja) 2008-11-14 2015-01-07 フィブロジェン インコーポレイテッド Hifヒドロキシラーゼ阻害剤としてのチオクロメン誘導体
RU2666144C2 (ru) 2013-01-24 2018-09-06 Фиброген, Инк. Кристаллические формы { [1-циано-5-(4-хлорофенокси)-4-гидроксиизохинолин-3-карбонил]-амино} -уксусной кислоты

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126326A (en) * 1989-06-06 1992-06-30 Bio-Mega, Inc. Enzyme inhibiting peptide derivatives

Also Published As

Publication number Publication date
PL169969B1 (pl) 1996-09-30
MX9205208A (es) 1993-03-01
FI924035A0 (fi) 1992-09-09
NZ244288A (en) 1995-03-28
AU2288992A (en) 1993-03-18
PL295905A1 (en) 1993-05-17
CZ280292A3 (en) 1994-01-19
KR930006050A (ko) 1993-04-20
HU9202925D0 (en) 1992-11-30
IL103126A (en) 1997-09-30
RU2067585C1 (ru) 1996-10-10
JPH05230095A (ja) 1993-09-07
HUT63632A (en) 1993-09-28
EP0532466A2 (de) 1993-03-17
FI924035A (fi) 1993-03-13
AU661018B2 (en) 1995-07-13
NO923533D0 (no) 1992-09-11
SK280292A3 (en) 1995-02-08
IL103126A0 (en) 1993-02-21
CA2077948A1 (en) 1993-03-13
EP0532466A3 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
NO923533L (no) Nye 5-amino-4-hydroksyheksansyrederivater som terapeutika
YU66201A (sh) Derivati amina kao inhibitori proteaze
ATE326454T1 (de) Neue bernsteinsäure derivative als cysteine- protease-inhibitoren
TW370529B (en) Pyrazolopyrimidines
DK0944617T3 (da) Krystaller af benzimidazolderivater og deres fremstilling
DK436081A (da) Substituerede acyl-derivater af 1,2,3,4-tetrahydroisoquinolin-3-carboxylsyrer og farmaceutisk acceptable salte deraf fremgangsmaade til deres fremstilling og deres anvendelse
NO20060703L (no) Fremgangsmate for fremstilling av cis-4-fluor-1-prolinderivater
NO954975L (no) Aromatisk substituerte w-amino-alkansyreamider og alkansyrediamider
ATE90107T1 (de) Peptide mit collagenase hemmender wirkung.
DK142084A (da) N-phenyl-n'-cycloalkylalkanoyl-piperaziner og fremgangsmaade til fremstilling heraf
RS20050182A (en) Derivatives of dioxane-2-alkyl carbamates,preparation method thereof and application of same in therapeutics
EP0353955A3 (en) Novel compounds
WO2008136444A1 (ja) 縮合複素環誘導体
WO2003008379A1 (fr) Composes azasucre
MY103348A (en) Heteroaryl 3-0x0-propanenitrile derivatives and process for their preparation
CO4950567A1 (es) Inhibidores de proteasas dores de proteasas.
AU2003207432A1 (en) Urea linker derivatives for use as ppar modulators
NO964698L (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
EP0202062A3 (en) Quinuclidine derivatives
MX2007004482A (es) Derivados de piridina y la preparacion y el uso terapeutico de los mismos.
YU46937B (sh) Derivati kondenzovanog pirazol-3-okso-propannitrila i postupak za njihovo dobijanje
DK0526313T3 (da) Nye ureaderivater, deres fremstilling og terapeutiske anvendelse
YU46706B (sh) Postupak za dobijanje amidnih jedinjenja
TW333532B (en) Benzopyrans
DE69910083D1 (de) Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten